Final answer:
The evidence that might indicate a need for increased enzyme dosages in a child with cystic fibrosis includes poor growth, steatorrhea, and abdominal pain, but not dysphagia.
Step-by-step explanation:
Evidence that a child with cystic fibrosis needs an increase in enzyme dosages might include poor growth, steatorrhea, and abdominal pain. However, dysphagia is not typically associated with the need for increased enzyme dosages in cystic fibrosis. Cystic fibrosis is an autosomal recessive genetic disease that affects multiple organs, primarily the lungs and digestive system, caused by a mutation in the CFTR gene. This mutation leads to the production of thick and sticky mucus that can cause malabsorption of nutrients and frequent lung infections. While there is no cure for cystic fibrosis, treatment has greatly improved, allowing individuals with this condition to live into their 30s and beyond.